Adversarial cooperation: some reflections prompted by commentaries.
Parker MJ., (2025), J Med Ethics, 52, 24 - 25
How should health researchers advance health equity?
Cheah PY. and Parker M., (2025), Trends Microbiol, 33, 1260 - 1263
Moral craft: engaging with value pluralism in healthcare decision-making.
Parker M., (2025), Monash Bioeth Rev, 43, 5 - 14
The Problem (and the Value) of Radical Moral Disagreement
Wilkinson D. et al, (2025), Wellcome Open Research
Life from death: ethical implications of uterus transplantation from deceased donors in global health.
Suwalowska H. et al, (2025), BMJ Glob Health, 10
Determining a role for Patient and Public Involvement and Engagement (PPIE) in genomic data governance for cancer care.
Sahan K. et al, (2025), Eur J Hum Genet
The Rare Therapies Launchpad: a pilot program for individualized medicines in the UK.
O'Connor DJ. et al, (2025), Nat Med, 31, 1379 - 1380
The value of large-scale programmes in human genomics.
Horn R. et al, (2025), Eur J Hum Genet, 33, 563 - 569
Author Correction: Call for a fairer approach to authorship in publishing biomedical research.
Cheah PY. and Parker M., (2025), Commun Med (Lond), 5
Call for a fairer approach to authorship in publishing biomedical research.
Cheah PY. and Parker M., (2025), Commun Med (Lond), 5
Equity and timeliness as factors in the effectiveness of an ethical prenatal sequencing service: reflections from parents and professionals.
Peter M. et al, (2025), Eur J Hum Genet, 33, 360 - 367
Artificial intelligence for modelling infectious disease epidemics.
Kraemer MUG. et al, (2025), Nature, 638, 623 - 635
“Looking at the Big Picture”: A Qualitative Study of Ethics in Science Communication and Engagement
Wilkinson C. et al, (2025), Science Communication
The Problem (and the Value) of Radical Moral Disagreement.
Lyreskog D. et al, (2025), Wellcome open research, 10
Rare disease genomic testing in the UK and Ireland: promoting timely and equitable access.
Ellard S. et al, (2024), J Med Genet, 61, 1103 - 1112
Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes.
Rots D. et al, (2024), Am J Hum Genet, 111, 1626 - 1642
Ethical preparedness in genomic medicine: how NHS clinical scientists navigate ethical issues.
Sahan K. et al, (2024), J Med Ethics, 50, 517 - 522